Kurin’s Push-Button Needle Tech Cleared by FDA

The FDA granted Kurin 510(k) clearance for its push-button needle technology, which the company says will support its future development of blood culture collection sets.

The company develops kits that automatically isolate potential contaminants during blood culture collection, which can lead to false positives and unnecessary treatment for patients.

“Kurin’s patented automatic blood discard product is the only FDA 510(k) cleared blood culture product in its class,” the company said.